Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 229,918 | reported | 27 May 2026 | tx 174+1,321,262−595,961 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 33,800 | 7.07 USD | |
| 27 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 33,800 | 26.78 USD | |
| 27 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 33,800 | 0.00 USD | deriv |
| 22 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,125 | — | |
| 26 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,966 | 26.78 USD | |
| 22 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,125 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,750 | — | |
| 22 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 2,358 | 26.78 USD | |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,750 | 0.00 USD | deriv |
| 17 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 1,774 | — | |
| 18 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,108 | 26.76 USD | |
| 17 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 1,774 | 0.00 USD | deriv |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,750 | — | |
| 23 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 4,347 | 15.57 USD | |
| 22 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,125 | — | |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,750 | 0.00 USD | deriv |
| 22 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,125 | 0.00 USD | deriv |
| 18 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,109 | 15.00 USD | |
| 17 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 1,774 | — | |
| 17 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 1,774 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,750 | — | |
| 24 Nov 2025 | SALE | KalVista Pharmaceuticals, Inc. | 4,331 | 13.45 USD | |
| 22 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,125 | — | |
| 21 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,750 | 0.00 USD | deriv |
| 22 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 3,125 | 0.00 USD | deriv |